TrialCancer medicine2022

Quality of life in patients with locally advanced head and neck squamous cell carcinoma undergoing concurrent chemoradiation with once-a-week versus once-every-3-weeks cisplatin.

Nandini S Menon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.